1 INVENTIONS - onlineservices.ipophil.gov.ph€¦ · [30] Priority Data: 61/371,984 09/08/2010 US [51] International Class 8: A61K 8/97 [57] Abstract: The present invention relates

Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines

Tel. No. 238-6300 Website: http://www.ipophil.gov.ph e-mail: [email protected] Volume 22 Number 6

Date Released: January 16, 2019

Invention Granted Under R.A. 8293 (PCT)

1 INVENTIONS

[19] INTELLECTUAL PROPERTY PHILIPPINES

[12] INVENTION GRANT

[21] Registration Number: 1/2012/502557 Document Code: B1

[45] Issue Date: 19 September 2018

[22] Date Filed: 26 December 2012

[54] Title: FROZEN CONFECTIONERY PRODUCTS WITH IMPROVED TEXTURE

[71] Proprietors(s): NESTEC S.A. [CH]

[72] Inventor(s):

UMMADI, Madhavi[US]: VAGHELA, Madansinh Nathusinh[US]: BUTTERWORTH, Aaron Beth[US]: PANDYA, Nirav Chandrakant[US]: McCUNE, Bridgett Lynn[US]: SCHMITT, Christophe Joseph Etienne[CH]: SAIKALI, Joumana[FR]

[73] Assignee(s): NESTEC S.A. [CH]

[74] Attorney / Agent: BENGZON NEGRE & UNTALAN

[30] Priority Data: 10171998.7 05/08/2010 EP

[51] International Class 8: A23G 9/38; A23G 9/40

[57] Abstract:

The present invention relates to a method for producing frozen confectionery products. In particular, the invention is concerned with a method which contributes to the improvement of textural and sensorial attributes of the confections obtained thereof, in particular of products based on lower fat formulations. The method includes the use of controlled heat (between 90°C and 140°C for 5 seconds to 30 minutes) on an acidified ice confection mix (pH between 5.6 and 6.5) to at least partially form a coagulated protein system including casein whey protein. Such a protein system is used according to the invention in frozen confection prepared by conventional freezing alone or combined with low temperature freezing wherein it improves the microstructure and stability on frozen products.

Representative Drawing(s): NONE

[56] Reference(s) Cited and/or Considered:

Document description

WO2010092091 (A1) (UMMADI MADHAVI et al.) 19 August 2010 (19.08.2010)

EP1342418 (A1) (GRAF ANDREAS WERNER) 10 September 2003 (10.09.2003)




US5413804 (A) (RHODES KENNETH H) 09 May 1995 (09.05.1995)

US4213896 (A) (DAVIS PAUL F.) 22 July 1980 (22.07.1980)

No. of Claims: 24








[22] Date Filed: 7 February 2013

[54] Title: ANTIMICROBIAL, ANTIBACTERIAL AND SPORE GERMINATION INHIBITING ACTIVITY FROM AN AVOCADO EXTRACT ENRICHED IN BIOACTIVE COMPOUNDS

[71] Proprietors(s): AVOMEX, INC. [US] and INSTITUTO TECNOLÓGICO Y DE ESTUDIOS SUPERIORES DE MONTERREY [MX]

[72] Inventor(s): HERNANDEZ-BRENES, Carmen[CR]: GARCIA-CRUZ, Maria Isabel[MX]: GUTIERREZ-URIBE, Janet Alejandra[MX]: BENAVIDES-LOZANO, Jorge Alejandro[MX]: RODRIGUEZ-SÁNCHEZ, Dariana Graciela[MX]

[73] Assignee(s): AVOMEX, INC. [US] and INSTITUTO TECNOLÓGICO Y DE ESTUDIOS SUPERIORES DE MONTERREY [MX]

[74] Attorney / Agent: A Q. ANCHETA & PARTNERS

[30] Priority Data: 61/371,984 09/08/2010 US

[51] International Class 8: A61K 8/97

[57] Abstract:

The present invention relates to extracts from Persea sp. (avocado) enriched in bioactive compounds which can be used as antimicrobial, antibacterial or spore germination inhibiting agents, the process for obtaining the extracts, acetogenins and isolated molecules and methods for using the extracts enriched in bioactive compounds for providing antimicrobial, antibacterial or spore germination inhibiting effect.

Representative Drawing(s):



“Acetyl-CoA Carboxylase Inhibitors from Avocado (Persea Americana Mill) Fruits.”,BIOSCIENCE, BIOTECHNOLOGY, AND BIOCHEMISTRY, vol. 65, no.7, pp. 1656-1658.




US 2 550 254 A

“Preliminary phytochemical screening and antimicrobial activity of seed extracts of Persea Americana (avocado pear)”, BAYERO JOURNAL OF PURE AND APPLIED SCIENCES, vol. 2, no. 1, pp. 173-176.

“Phytochemical analysis of avocado seeds (Persea Americana Mill., C.v. Hass)” (Dissertation), Publsihed by Cuviller Verlag.

No. of Claims: 97








[22] Date Filed: 21 June 2013

[54] Title: ACTIVE PROTEASE-RESISTANT ANTIBODY FC MUTANTS

[71] Proprietors(s): JANSSEN BIOTECH, INC. [US]

[72] Inventor(s): STROHL, William[US]: JORDAN, Robert[US]: BREZSKI, Randall[US]

[73] Assignee(s): JANSSEN BIOTECH, INC. [US]

[74] Attorney / Agent: ROMULO MABANTA BUENAVENTURA SAYOC AND DE LOS ANGELES

[30] Priority Data: 61/426,619 23/12/2010 US and 61/540,882 29/09/2011 US

[51] International Class 8: A61K 39/00

[57] Abstract:

Monoclonal antibody and other Fc-containing molecules can be constructed using the disclosed variations in the Fc region causing increased resistance to host and pathogen-derived proteases and exhibiting the ability to interact with Fey receptors and initiate complement directed cytotoxicity as demonstrated by functional assays. The Fc-containing molecules are useful in the treatment of various diseases and disorders wherein FcR-driven host functions contribute activity.




US 2008/0206867 A1 (Desjarlais, et al.) 28 August 2008

US 2010/0298542 A1 (Igawa, et al.) 25 November 2010

US 2009/0155280 A1 (Jordan, et al.) 18 June 2009

No. of Claims: 28








[22] Date Filed: 14 November 2013

[54] Title: FAMILY OF ARYL, HETEROARYL, O-ARYL AND O-HETEROARYL CARBASUGARS

[71] Proprietors(s): TFCHEM [FR]

[72] Inventor(s): DELIENCOURT-GODEFROY, Géraldine[FR]: LOPES, Lénaïg[FR]

[73] Assignee(s): TFCHEM [FR]

[74] Attorney / Agent: ROMULO MABANTA BUENAVENTURA SAYOC AND DELOS ANGELES

[30] Priority Data: 11305645.1 26/05/2011 EP

[51] International Class 8: A61K 31/085; A61K 31/381; A61K 31/415; A61P 29/00; A61P 3/04; A61P 3/10; A61P 31/00; A61P 31/12; A61P 35/00; C07C 43/225; C07C 43/23; C07C 43/247; C07C 43/253; C07D 231/20; C07D 333/16

[57] Abstract:

The present invention relates to a compound of the following formula (I): as well as its process of preparation, pharmaceutical and cosmetics composition comprising it and use thereof, notably as an inhibitor of the sodium-dependent glucose co-transporter, such as SGLTl, SGLT2 and SGLT3, in particular in the treatment or prevention of diabetes, and more particularly type-II diabetes, diabetes-related complications, such as arthritis of the lower extremities, cardiac infarction, renal insufficiency, neuropathy or blindness, hyperglycemia, hyperinsulinemia, obesity, hypertriglyceridemia, X syndrome and arteriosclerosis, as well as for its use as an anticancer, anti-infective, anti-viral, anti-thrombotic or anti- inflammatory drug, or for lightening, bleaching, depigmenting the skin, removing blemishes from the skin, particularly age spots and freckles, or preventing pigmentation of the skin.




WO 2009/076550 A1 (THERACOS INC [US] ; CHEN YUANWEI [US] ; PENG KUN [CN] ; ZHANG LILI [CN]) 18 June 2009

WO 2005/044256 A1(MERCK & CO INC [US] ; SINGS HEATHER




I [US] ; UJJAINWALLA FEROZE [US] ; MA) 19 May 2005

No. of Claims: 108









[54] Title: SOLID OXIDIZED GLUTATHIONE SALT AND METHOD FOR PRODUCING SAME

[71] Proprietors(s): KANEKA CORPORATION [JP]

[72] Inventor(s): MOURI, Taku[JP]: TAOKA, Naoaki[JP]: MOROSHIMA, Tadashi[JP]: KINOSHITA, Koichi[JP]

[73] Assignee(s): KANEKA CORPORATION [JP]

[74] Attorney / Agent: SIGUION REYNA MONTECILLO & ONGSIAKO LAW OFFICES

[30] Priority Data: 2011-146574 30/06/2011 JP

[51] International Class 8: A23L 1/305; A61K 38/00; A61K 47/06; A61K 47/08; A61K 47/10; A61K 47/14; A61K 47/20; A61K 8/64; A61K 9/08; A61K 9/10; A61K 9/14; C07K 5/037; C07K 5/093

[57] Abstract:

A solid oxidized glutathione salt is produced by heating oxidized glutathione to at least 30°C while bringing the oxidized glutathione into contact with an aqueous medium composed of water and/or a water-soluble medium, in the presence of a substance capable of generating at least one type of cation selected from ammonium cations, calcium cations, and magnesium cations, so as to produce a salt of the oxidized glutathione and the cation as a solid.




D1 US6251857 B1 (KOZHEMYAKIN LEONID ET AL.) 26 JUNE 2001

D2 US 2007/123450 A1 (KOZHEMYAKIN LEONID ET AL.) 31 MAY 2007

No. of Claims: 18









[54] Title: ANTI-ANGPTL3 ANTIBODIES AND USES THEREOF

[71] Proprietors(s): REGENERON PHARMACEUTICALS, INC. [US]

[72] Inventor(s): SLEEMAN, Mark, W.[AU]: GUSAROVA, Viktoria[US]: MURPHY, Andrew, J.[US]

[73] Assignee(s): REGENERON PHARMACEUTICALS, INC. [US]

[74] Attorney / Agent: CESAR C. CRUZ AND PARTNERS


[51] International Class 8: A61K 39/395; A61P 3/06; C07K 16/22

[57] Abstract:

A fully human antibody or antigen-binding fragment of a human antibody that specifically binds and inhibits or interferes with at least one activity of human angiopoietin-like protein 3 (hANGPTL3) is provided. The human anti-hANGPTL3 antibodies are useful in treating diseases or disorders associated with ANGPTL3, such as hyperlipidemia, hyperlipoproteinemia and dyslipidemia, including hypertriglyceridemia, hypercholesterolemia, chylomicronemia, and so forth. Furthermore, the anti-hANGPTL3 antibodies can be administered to a subject in need thereof to prevent or treat diseases or disorders, for which abnormal lipid metabolism is a risk factor. Such diseases or disorders include cardiovascular diseases, such as atherosclerosis and coronary artery diseases; acute pancreatitis; nonalcoholic steatohepatitis (NASH); diabetes; obesity; and the like.




WO 2008/073300 A2 (LEXICON PHARMACEUTICALS INC.) 19 June 2008

E-C. LEE et al., "Identif of a New Func. Domain in ANGPTL3 and ANGPTL4 Involved in Binding and Inhibition of LPL", JOURNAL OF BIO CHEM, vol. 284. no. 20. 15 May 2009 p. 13735-13745

No. of Claims: 12








[22] Date Filed: 28 March 2014

[54] Title: CONTENT MANAGEMENT SYSTEMS, METHODS, APPARATUS AND USER INTERFACES

[71] Proprietors(s): TRANSCITY GROUP PTY LTD [AU]

[72] Inventor(s): ALFORD, James[AU]: MCNAIR, David[--]

[73] Assignee(s): TRANSCITY GROUP PTY LTD [AU]

[74] Attorney / Agent: SYCIP SALAZAR HERNANDEZ AND GATMAITAN

[30] Priority Data: 2011903999 28/09/2011 AU

[51] International Class 8: H04N 21/431

[57] Abstract:

The invention generally relates to content management systems, methods, apparatus and user interfaces for transmitting, displaying and enabling the manipulation of content from multiple sources. In one embodiment, a system for managing content supplied from a plurality of sources in respective signals includes a server for transmitting a multicast stream comprising streams representing the signals from the plurality of sources and one or more apparatus coupled to be in communication with the server and subscribing to the multicast stream. Each apparatus includes a plurality of player objects, each of which is paired with a constituent stream of the multicast stream. The apparatus also comprises at least one viewing object coupled with one of the player objects to display content from the stream paired with the respective player object.







US2010113157 A1 / AT & T IP I LP / 06 May 2010

No. of Claims: 22








[22] Date Filed: 28 April 2014

[54] Title: HUMANIZED ANTIBODIES THAT RECOGNIZE ALPHA-SYNUCLEIN

[71] Proprietors(s): PROTHENA BIOSCIENCES LIMITED [IE]

[72] Inventor(s): SALDANHA, Jose [GB]: NIJJAR, Tarlochan S.[US]

[73] Assignee(s): PROTHENA BIOSCIENCES LIMITED [IE]

[74] Attorney / Agent: SAPALO VELEZ BUNDANG & BULILAN


[51] International Class 8: A61K 39/00; A61K 39/395; C07K 16/00

[57] Abstract: The present application discloses humanized 9E4 antibodies. The antibodies bind to human alpha synuclein and can be used for immunotherapy of Lewy body disease.




WO 2008/103472 A2 (ELAN PHARM INC. ET AL.) AUGUST 28, 2008

WO 2007/011907 (UNIV ROCHESTER ET AL.) 25 JANUARY 2007

No. of Claims: 61









[54] Title: COMBINATION TREATMENT OF CANCER

[71] Proprietors(s): ASTRAZENECA AB [SE]

[72] Inventor(s): DAVIES, Barry, Robert[GB]

[73] Assignee(s): ASTRAZENECA AB [SE]

[74] Attorney / Agent: ORBOS CABUSORA & TAGUIAM

[30] Priority Data: 61/564,975 30/11/2011 US

[51] International Class 8: A61K 31/519; A61P 13/08; A61P 35/00

[57] Abstract:

The present invention relates to a combination comprising AZD5363, or a pharmaceutically acceptable salt thereof, and at least one androgen receptor signalling modulator selected from MDV-3100 (also known as enzalutamide), AZD3514, abiraterone (or an ester prodrug thereof: e.g. abiraterone acetate), and bicalutamide; or a pharmaceutically acceptable salt thereof. Each of these combinations may be useful in the treatment of cancer. The invention also relates to pharmaceutical compositions comprising such combinations, and further relates to methods of treatment comprising the simultaneous, sequential or separate administration of AZD5363, or a pharmaceutically acceptable salt thereof, with at least one androgen receptor signalling modulator as described above, to warm-blooded animal, such as a human for the treatment of cancer. The invention also relates to a kit comprising such combinations.







WO 2010/091306 A1 (TOKAI PHARMACEUTICALS, CASEBIER DAVID) 12 AUGUST 2010

WO 2004/066962 A2 (CASTLE, E.P.) 12 AUGUST 2004

No. of Claims: 12








[22] Date Filed: 8 May 2014

[54] Title: PURINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS

[71] Proprietors(s): JANSSEN SCIENCES IRELAND UC [IE]

[72] Inventor(s):

BONFANTI, Jean-François[FR]: DOUBLET, Frédéric Marc Maurice[FR]: EMBRECHTS, Werner[BE]: FORTIN, Jérôme Michel Claude[FR]: MC GOWAN, David Craig[BE]: MULLER, Philippe[FR]: RABOISSON, Pierre Jean-Marie Bernard[BE]

[73] Assignee(s): JANSSEN SCIENCES IRELAND UC [IE]

[74] Attorney / Agent: HECHANOVA AND CO., INC.

[30] Priority Data: 11188511.7 09/11/2011 EP

[51] International Class 8: A61K 31/522; A61P 31/12; C07D 473/34; C07D 519/00

[57] Abstract: The present invention relates to purine derivatives of formula (I), processes for their preparation, pharmaceutical compositions, and their use in treating viral infections.




WO 2008/114008 A1 (ASTRAZENECA AB ET AL.) 25 SEPTEMBER 2008

WO 2011/049825 A1 (GILEAD SCIENCES INC. ET AL.) 28 APRIL 2011

No. of Claims: 5








[22] Date Filed: 11 July 2014

[54] Title: HAND-HELD DEVICE FOR ELECTRICALLY POWERED SKIN TREATMENT

[71] Proprietors(s): SWISS SPA SYSTEM LTD. [CN]

[72] Inventor(s): GIMELLI, Bruno[CH]: DOYLE, Jr., James N[US]

[73] Assignee(s): SWISS SPA SYSTEM LTD. [CN]

[74] Attorney / Agent: ATTY. ANNA LIZA ANG CO

[30] Priority Data: 10 2012 000 563.6 16/01/2012 DE and 10 2012 009 514.7 14/05/2012 DE

[51] International Class 8: A61H 7/00; A61N 1/04; A61N 1/32

[57] Abstract:

The invention relates to a hand-held device for electrically powered skin treatment, whereby current is passed into the skin from an external electric circuit via an electrode (20) so that active ingredients of a cream applied to the skin can better penetrate into the skin. To aid this effect, a cap (9) of the device, which functions as an electrode (20), is provided with a vibrator (15) so that the electrode (20) vibrates on the skin, thus working the cream into the skin.




WO 2005/087308 A1 / PROVENTURE (FAR EAST) LIMITED [US] / 22 September 2005 (22.09.2005)

EP 2384707 A1 / BRAUN GmbH / 09 November 2011 (09.11.2011)

US 6385487 B1 / HENLEY, Julian L. / 07 May 2002 (07.05.2002)

EP 2277585 A2 / BIOPHORETIC THERAPEUTIC SYSTEM, LLC / 26 January 2011 (26.01.2011)

No. of Claims: 28








[22] Date Filed: 11 July 2014

[54] Title: ANTI-ASIC1 ANTIBODIES AND USES THEREOF

[71] Proprietors(s): REGENERON PHARMACEUTICALS, INC. [US]

[72] Inventor(s): MACDONALD, Lynn[US]: GAO, Min[US]: MORRA, Marc., R[US]: ALESSANDRI-HABER, Nicole, M[US]: LaCROIX-FRALISH, Michael, L[US]

[73] Assignee(s): REGENERON PHARMACEUTICALS, INC. [US]

[74] Attorney / Agent: CESAR C. CRUZ AND PARTNERS

[30] Priority Data: 61/592,837 31/01/2012 US; 61/644,038 08/05/2012 US and 61/692,925 24/08/2012 US

[51] International Class 8: A61K 39/395; A61P 29/00; C07K 16/18

[57] Abstract:

The present invention provides antibodies and antigen-binding fragments thereof that specifically bind to cells expressing acid-sensing ion channel-1 (ASIC1). According to certain embodiments of the invention, the antibodies inhibit acid-induced, ASIC1-mediated ion currents in cells expressing human ASIC1. The antibodies of the invention are useful for the treatment of pain, including pain associated with surgical intervention and various diseases and disorders.




WO 2011/051349 A1 UCB PHARMA SA 05 May 2011

No. of Claims: 18








[22] Date Filed: 17 September 2014

[54] Title: SELECTIVE SEPARATION OF HEAVY COKER GAS OIL

[71] Proprietors(s): Foster Wheeler USA Corporation [US]

[72] Inventor(s): GILLIS, Daniel, B[US]

[73] Assignee(s): Foster Wheeler USA Corporation [US]

[74] Attorney / Agent: MIRANDAH ASIA (PHILIPPINES) INC.

[30] Priority Data: 61/612,860 19/03/2012 US

[51] International Class 8: C10G 53/04

[57] Abstract: Embodiments of the invention are directed to the improvement of the design of coker systems and processes in order to improve the yields and separation of heavy coker gas oils derived therefrom.




US 2008/0116109 A1 (McCoy, et. al.), 22 May 2008

WO 98/36036 [Conoco Inc. (US)], 20 Auust 1998

Maples, R.E. (2000). Petroleum Refinery Process Economics, 2nd ed., PennWell, 474 pgs.

US 5,645,712 (Roth [US]), 08 July 1997

US 4,435,275 (Derr, et. al.), 06 March 1984

US 4,200,519 (Kwant, et. al.), 29 April 1980

US 20100329936 (Van Wees, et. al.), 30 December 2010




US 5,824,194 (Kruse), 20 October 1998

No. of Claims: 16








[22] Date Filed: 17 September 2014

[54] Title: METHOD FOR REDUCING SILICONE ANTIFOAM USAGE IN DELAYED COKING PROCESSES

[71] Proprietors(s): FOSTER WHEELER USA CORPORATION [US]

[72] Inventor(s): ELLIOTT, John Daniel[US]: WAGGONER, Jerry Neil[US]

[73] Assignee(s): FOSTER WHEELER USA CORPORATION [US]

[74] Attorney / Agent: MIRANDAH ASIA (PHILIPPINES) INC

[30] Priority Data: 61/612,852 19/03/2012 US

[51] International Class 8: B01D 19/04; C10B 55/00; C10B 57/12; C10G 9/00; C10G 9/14

[57] Abstract:

The current invention provides an improved petroleum coking process wherein the risk of silicone poisoning of units downstream of the coke drums is reduced. The method of the current invention controls the foam layer within the coke drum by injection of a silicone anti-foam agent in a highly aromatic carrier fluid such as slurry oil.




US 7,427,350 B2 (Kremer), 23 September 2008

US 4,969,988 A (Jain, et al.), 13 November 1990

US 4,961,840 A (Goyal), 09 October 1990

US 2010/0116473 A1 (Yang, et al.), 13 May 2010

US 2010/0300940 A1 (Volk, Jr.), 02 December 2010

US 2012/0103868 A1 (Dindi, et al.), 03 May 2012

No. of Claims: 4









[54] Title: BONE FUSION DEVICE

[71] Proprietors(s): NEUROPRO TECHNOLOGIES, INC. [US]

[72] Inventor(s): MCLUEN, Gary R[US]: REMINGTON, Benjamin J[US]: BAKER, Daniel R[US]: LOGAN, Joseph N[US]: STALCUP, Gregory C[US]

[73] Assignee(s): NEUROPRO TECHNOLOGIES, INC. [US]

[74] Attorney / Agent: HECHANOVA AND CO., INC.

[30] Priority Data: 13/482,778 29/05/2012 US

[51] International Class 8: A61F 2/44

[57] Abstract:

A bone fusion device provides stability to bones during a bone fusion period. The bones include, for example, the vertebrae of a spinal column. The bone fusion device comprises one or more extendable tabs attached to the bone fusion device by associated rotating means. The bone fusion device is preferably inserted by using an arthroscopic surgical procedure. During arthroscopic insertion of the device, the tabs are pre-configured for compactness. In this compact configuration, the tabs are preferably deposed along and/or within an exterior surface of the bone fusion device. After the bone fusion device has been positioned between the bones, one or more tab(s) are extended. In the preferred embodiment, the position of each tab is related to a positioning element and extending blocks. Typically, the tabs advantageously position and brace the bone fusion device in the confined space between the bones until the bones have fused.







US4863476, SHEPPERD, JOHN, 05 September 1989

US4961740, RAY, CHARLES D., 09 October 1990

No. of Claims: 8









[54] Title: FILTER PAPER QUICKLY DISINTERGRATING IN WATER

[71] Proprietors(s): DELFORTGROUP AG [AT]

[72] Inventor(s): BACHMANN, Stefan[AT]: VOLGGER, Dietmar[AT]: MÖHRING, Dieter[AT]: PESENDORFER, Kannika[AT]: REITER, Guido[AT]

[73] Assignee(s): DELFORTGROUP AG [AT]

[74] Attorney / Agent: E. B. ASTUDILLO & ASSOCIATES

[30] Priority Data: 10 2012 106 801.1 26/07/2012 DE

[51] International Class 8: A24D 1/02; A24D 3/06; A24D 3/10; D21H 11/20; D21H 15/06; D21H 27/00

[57] Abstract:

The invention relates to a paper that quickly disintegrates in water, for use as filter material or filter wrapper paper of a cigarette filter, having the following properties: At least 80 wt %, preferably at least 90 wt %, and particularly preferably at least 95 wt %of the paper is formed by cellulose fibers. Of said cellulose fibers, at least 80 wt %, preferably at least 90 weight percent, and particularly preferably at least 95 wt %are a mixture of long fiber pulp and mercerized pulp. 0 to 90 wt %of the content of said mixture is mercerized pulp, and the rest is long fiber pulp. The cellulose fibers of said mixture have a freeness of at most 30°SR, preferably at most 25°SR, and particularly preferably at most 20°SR, according to ISO 5267. In the disintegration test using a device as described in TAPPI T 261, the paper shows a disintegration of at least 60%, preferably of at least 70%, and particularly preferably of at least 80% after 30 seconds.




US5678577; SHIMAMOTO, SYU, et. al., 20 October 1997

US5758669; TANIGUCHI HIROKI, et. al., 02 June1998

No. of Claims: 21









[54] Title: APPARATUS AND METHOD FOR ULTRASOUND SCREENING

[71] Proprietors(s): ARTECH ULTRASONIC SYSTEMS AG [CH]

[72] Inventor(s): KISING, Jürgen[CH]

[73] Assignee(s): ARTECH ULTRASONIC SYSTEMS AG [CH]

[74] Attorney / Agent: PATRICK MIRANDAH CO. PHILIPPINES, INC.

[30] Priority Data: 10 2012 108 529.3 12/09/2012 DE

[51] International Class 8: B07B 1/34; B07B 1/40; B07B 1/42; B07B 1/46; B07B 1/50

[57] Abstract:

An apparatus for ultrasound screening with a screen frame a screen fabric arranged in the screen frame with at least one ultrasound converter for producing ultrasonic vibrations. Ultrasonic vibrations may be introduced into the screen fabric via sound-conducting connection with the ultrasound converter, and the location of the screen fabric at which the introduction of the ultrasonic vibrations into the screen fabric may be varied.




US5213216, SUEHIRO, ATSUO, et. al. 25 May 1993

US5653346, FREI, KARL, et. al. 05 August 1997

No. of Claims: 18









[54] Title: COATED PHARMACEUTICAL COMPOSITION CONTAINING REGORAFENIB

[71] Proprietors(s): BAYER HEALTHCARE LLC. [US]

[72] Inventor(s): SKRABS, Dr. Susanne[DE]: FUNKE, Dr. Adrian[DE]: KRESSE, Dr. Mayk[DE]: OBERDIECK, Dr. Ulrich[DE]

[73] Assignee(s): BAYER HEALTHCARE LLC. [US]

[74] Attorney / Agent: ORTEGA, BACORRO, ODULIO, CALMA & CARBONELL

[30] Priority Data: 12183331.3 06/09/2012 EP

[51] International Class 8: A61K 31/4412; A61K 9/28

[57] Abstract:

The present invention relates to a coated pharmaceutical composition containing regorafenib, a hydrate, solvate, metabolite or pharmaceutically acceptable salt thereof or a polymorph thereof and its process of preparation and its use for treating disorders.




WO 2006/026500 A1 (BAYER PHARMACEUTICAL CORP [US]) 9 March 2006 (09.03.2006)

WO 2007/068381 A1 (BAYER HEALTHCARE AG [DE]) 21 June 2007 (21.06.2007)

No. of Claims: 39









[54] Title: GYPSUM COMPOSITION, GYPSUM SLURRY, GYPSUM HARDENED BODY, GYPSUM-BASED BUILDING MATERIAL, GYPSUM BOARD, AND MANUFACTURING METHOD FOR A GYPSUM-BASED BUILDING MATERIAL

[71] Proprietors(s): YOSHINO GYPSUM CO., LTD. [JP]

[72] Inventor(s): ATAKA, Yuji[JP]: SATO, Yosuke[JP]

[73] Assignee(s): YOSHINO GYPSUM CO., LTD. [JP]

[74] Attorney / Agent: SALUDO FERNANDEZ AQUINO & TALEON LAW OFFICES

[30] Priority Data: 2012-200953 12/09/2012 JP

[51] International Class 8: B28B 1/30; B28B 1/50; C04B 24/38; C04B 28/14

[57] Abstract:

[Problems] An object is to provide a gypsum composition, a gypsum slurry, a gypsum hardened boy, a gypsum-based building material, a gypsum board, and a manufacturing method for a gypsum-based building material so that it is possible to obtained a gypsum hardened body with a high strength without drastically increasing an amount of added water when a gypsum slurry is provided. [Solving means] A gypsum composition, a gypsum slurry, a gypsum hardened body, a gypsum-based building material, a gypsum board, and a manufacturing method for a gypsum-based building material are provided so that a calcined gypsum and a starch urea phosphate are included.




US 7,208,068 B2 (NISOGI, HIDEAKI [JP], et.al.) 24 April 2007

US 7,682,438 B2 (SONG, JAY C. [US], et.al.) 23 March 2010

US 2013/0011553 A1 (MURAMATSU, RIICHI [JP], et.al.) 10 January 2013

No. of Claims: 13








[22] Date Filed: 10 May 2016

[54] Title: APPARATUS, METHOD AND ARTICLE FOR PROVIDING VEHICLE EVENT DATA

[71] Proprietors(s): GOGORO INC. [CN]

[72] Inventor(s): TAYLOR, Matthew, Whiting[US]: LUKE, Hok-Sum Horace[US]

[73] Assignee(s): GOGORO INC. [CN]

[74] Attorney / Agent: SAPALO VELEZ BUNDANG & BULILAN LAW OFFICES

[30] Priority Data: 61/901,660 08/11/2013 US

[51] International Class 8: B60R 16/02

[57] Abstract:

Detected events such as impacts, accidents, breakdowns, and types of driving behaviors based on feedback from tilt, gravity, accelerometers and/or shock sensors within a portable electrical power storage device such as a battery and/or within a vehicle (e.g., an electric scooter) are communicated to the user's mobile device, dashboard display and/or backend systems over wired and/or wireless communication channels. The communication of the events and types of events are logged and automatically aggregated from multiple vehicles for further analysis to determine various potential system-wide safety issues and to track event history on an individual per-user or individual per-scooter basis or individual per-battery basis. Such event data may also be transferred accordingly via the battery exchange process at the online exchange machine through a memory device attached to the battery that stores the event data.




US 2013-0031318 A1 CHEN et al. 31 January 2013

WO 2013-098873 A1 KAWASAKI JUKOGYO KABUSHIKI KAISHA 04 July 2013




US 2013-0030920 A1 WU et al. 31 January 2013

JP 2001-128301 A YAMAHA MOTOR CO., LTD. 11 May 2001

US 2003-0209375 Al SUZUKI et al. 13 November 2003

No. of Claims: 7

Documents

1 INVENTIONS - onlineservices.ipophil.gov.ph€¦ · [30] Priority Data: 61/371,984 09/08/2010 US [51] International Class 8: A61K 8/97 [57] Abstract: The present invention relates